About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Disclaimer

Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« IPR Update -- Is Reviewability of Time-Bar Institution Decisions Headed En Banc? | Main | Guest Post -- The Emergent Microbiome: A Revolution for the Life Sciences -- Part IX, The Microbiome and Immunotherapy II »

December 05, 2016

Comments

Hey Andrew,

Given that the Federal Circuit ruled in favor of the patent owner, it's almost a given that SCOTUS will reverse. But given what transpired during the oral argument, I wouldn't hold my breath on SCOTUS providing any meaningful definition/guidelines on what "all or a substantial portion" means in 271(f)(2). Given that SCOTUS cowardly "punted" on what "article of manufacture" means in the Apple v. Samsung, they could do the same in Life Tech v. Promega.

One has to wonder what exactly frightens the Supreme Court as to having brightline rules in place for patent law.

Hey Andrew,

My apologies, I should have said "271(f)(1)," not "271(f)(2)." That SCOTUS is more than likely to come out with a wishy-washy view of what "all or a substantial portion" won't surprise. SCOTUS proved in Microsoft v. AT&T that they don't understand the language in either subsection of 271(f) because they're unwilling, unlike the Federal Circuit in Waymark that interpreted the language of 271(f) correctly, to loosen their Olympic grip on the dead hand of Deepsouth Packing.

The comments to this entry are closed.

June 2025

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30